Hematological Disease | Registry of Febrile Neutropenia and Invasive Fungal Infections
Hematological Disease research study
What is the primary objective of this study?
Objectives： 1. To assess the percentage of febrile neutropenia and suspected fungal-related febrile episodes in patients receiving chemotherapy 2. To explore the percentage/distribution of infectious origins of febrile neutropenia 3. To explore the percentage/distribution of infectious pathogens of febrile neutropenia 4. To explore clinical outcomes of different infectious origins/pathogens in febrile neutropenia episodes 5. To have a clear view of therapeutic actions in the management of hematological patients with febrile neutropenia and suspected fungal-related febrile episodes
Who is eligible to participate?
Inclusion Criteria: - Patients with new diagnosed hematological diseases (acute and chronic myeloid and lymphoid leukemia, multiple myeloma, non-Hodgkin's and Hodgkin's lymphoma, myelodysplastic syndromes) - Patients who are receiving chemotherapy and have ongoing febrile episodes Exclusion Criteria:
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Other:Patient registryPatient registry without study intervention
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Patient registryPatients with newly diagnosed malignant hematological diseases will be enrolled into this registry
Start Date: November 2011
Completed Date: August 2013
Study sponsors, principal investigator, and references
Principal Investigator: Ming-Chung Wang, M.D.
Lead Sponsor: Chang Gung Memorial Hospital